Journal article
Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline
Abstract
PURPOSE: To provide evidence-based recommendations updating the 2020 ASCO and Ontario Health (Cancer Care Ontario) guideline on systemic therapy for patients with stage IV non-small-cell lung cancer without driver alterations.
METHODS: ASCO updated recommendations on the basis of an ongoing systematic review of randomized clinical trials from 2018 to 2021.
Authors
Singh N; Temin S; Baker S; Blanchard E; Brahmer JR; Celano P; Duma N; Ellis PM; Elkins IB; Haddad RY
Journal
Journal of Clinical Oncology, Vol. 40, No. 28, pp. 3323–3343
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
October 1, 2022
DOI
10.1200/jco.22.00825
ISSN
0732-183X